S22-373 Broadly neutralizing antibodies against sarbecoviruses Stanford scientists have developed broadly neutralizing antibodies against sarbecoviruses , including SARS-CoV-2 related Clade 1b, SARS-CoV related Clade 1a and Clade 3 viruses, paving the way for future vaccines and therapeutics. Bali Pulendran Yupeng Feng